CAY001
Life-threatening Hemorrhage (e.g., trauma, surgery, anticoagulant-related)
Key Facts
About Cayuga Biotech
Cayuga Biotech is an innovative biopharmaceutical company targeting the massive and underserved global market for hemorrhage control. Founded on proprietary science, the company is developing novel, biomimetic small molecule therapies aimed at rapidly stopping bleeding in situations where current treatments fail, such as trauma, surgery, and in patients on blood thinners. Led by a seasoned team with deep experience in drug development and commercialization, including prior work on approved hemorrhage therapeutics, Cayuga is positioned to advance its pipeline through key preclinical and clinical milestones. The company operates as a private, pre-revenue entity seeking to transform outcomes in a critical area of medicine.
View full company profile